HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ : IVCP) With Goal to Transform Cardiovascular Disease Treatment - Marketscreener.com

1 min to read

HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ : IVCP) With Goal to Transform Cardiovascular Disease Treatment – Marketscreener.com

Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to November 3, 2024

Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to November 3, 2024 ...
Fashion Companies Seeking Office Space Are Flocking To DTLA

Downtown Los Angeles is weathering one of its slowest office leasing environments in history, but a spate of new tenants...
ArentFox Schiff To Relocate Downtown HQ To Space Fannie Mae Is Giving Up

ArentFox Schiff is moving its headquarters to Midtown Center, filling a large chunk of the footprint Fannie Mae is planning to vacate. Source: ArentFox...
ART SHARE 003 – Extension of the Offer Period of the iconic artwork ‘Abstraktes Bild (809-4)’ by Gerhard Richter

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES,...
BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement

RICHMOND, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...